ArticleTropical parasitology
Clinical and epidemiological profile of severe imported
Article in Tropical parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: This study aimed to characterize the epidemiological patterns of imported severe malaria cases between 2020 and 2023 and investigate the most common serious clinical presentations observed at the time of hospital admission. Understanding these patterns would contribute to improved patient care and treatment protocols. Materials and Methods: This single-center, retrospective study analyzed the records of patients treated for severe imported malaria at Moscow's Infectious Diseases State Hospital No. 2 between 2020 and 2023. Results: In total, 32 patients met the World Health Organization (WHO) criteria for severe malaria. The study group had a median age of 41 (interquartile range [IQR]: 36-52), was predominantly male (89%), and consisted mostly of individuals of Russian descent (91.2%). Nearly all acquired their infection in sub-Saharan African countries. No patient used malaria chemoprophylaxis before, during, or after visit to these countries. Patients typically sought medical attention a median of 5 days after their symptoms first appeared (IQR: 4-6). Conclusion: The findings emphasize the crucial role that antimalarial medication and prompt medical attention play in both preventing malaria and mitigating its severity. Prompt diagnosis and treatment of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.